February 13, 2014

Janssen Biotech announced that the Food and Drug Administration has approved Imbruvica (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy.

February 13, 2014

Teva Pharmaceutical Industries announced that the Food and Drug Administration has granted full approval of Synribo (omacetaxine mepesuccinate) for injection.

February 12, 2014

Mallinckrodt and Cadence Pharmaceuticals on Tuesday announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals for $14.00 per share in cash.

February 11, 2014

The Generic Pharmaceutical Association announced its support of Georgia SB 370, introduced by pharmacist and Sen. Buddy Carter, R-Ga. District 1, because it will allow unimpeded patient access to interchangeable biologics.

February 11, 2014

The Pharmacy Benefit Management Institute recently released its Specialty Drug Benefit Report, sponsored by Walgreens Specialty Pharmacy.

February 11, 2014

In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists’ training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise, the retailer announced Tuesday.

February 10, 2014

Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.

February 7, 2014

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

February 7, 2014

Selecting a doctor can be a frustrating process filled with too many unknowns, especially in today’s evolving landscape.

February 6, 2014

Diplomat on Wednesday released its second episode in partnership with Pharmacy Podcast.

February 5, 2014

CVS Caremark was awarded the 2014 Rx Benefit Innovation Award by the Pharmacy Benefit Management Institute on Tuesday, the company reported.

February 4, 2014

Cornerstone Therapeutics, a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, on Monday announced that its stockholders have approved, at a special stockholder meeting, the previously announced merger agreement, under which Chiesi Farmaceutici S.p.A. will acquire all of the outstanding common shares of Cornerstone for $9.50 per share in cash.

February 4, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday announced a partnership with the National Institutes of Health that will help spur drug development, the association stated.

January 31, 2014

Actavis on Friday announced a realignment of its global strategic business structure to maximize the company's newly strengthened position as a leading specialty pharmaceutical developer, manufacturer and marketer, and to enhance Actavis' position for continued long-term growth.

January 31, 2014

Avella Specialty Pharmacy on Thursday named Rebecca Shanahan CEO. Shanahan brings more than two decades of successful leadership experience in the healthcare sector, as well as five years of service on Avella’s board of directors, to her new role.

January 31, 2014

The imminent entry of several companies — including big pharma, small biotech and generic participants — into the global biosimilars space will propel the market toward exponential growth. The market is expected to soar from $1.2 billion in 2013 to $24 billion in 2019, reported Frost & Sullivan in research released earlier this week.

January 31, 2014

Mylan announced that its India-based subsidiary, Mylan Pharmaceuticals Private Limited, has been named Gilead Sciences' branded medicines business partner for India.

January 30, 2014

The loss of the Walgreens contract was a key consideration in Cardinal Health's 12% decline in overall revenue for the company's second quarter 2014, George Barrett, Cardinal Health chairman and CEO, told analysts Thursday morning.

January 30, 2014

A new web platform has gone live from Diplomat, the nation’s largest independent specialty pharmacy reported.

January 30, 2014

Diplomat Pharmacy on Thursday announced that it will be partnering with The Whiting, Flint’s premier performing arts venue on bringing new entertainment opportunities to the area through the Gen X Concert Series.

January 29, 2014

Almost two-thirds of specialty pharmacy revenues are attributed to 1-of-3 companies, and the specialty pharmacy market is poised to explode, according to a Drug Channels Institute report.

January 29, 2014

Teva announced that the Food and Drug Administration approved its supplemental new drug application for three-times-a-week Copaxone in 40mg/mL form.

January 28, 2014

Hamacher Resource Group has announced that is offering its workshop, How to Grow Sales Within Independent Pharmacy, again on March 6 at its headquarters in Waukesha, Wis.

January 27, 2014

ScriptCycle, a technology company that serves pharmacies and patients, will launch its comprehensive cash solutions for retail pharmacies at the NACDS Regional Conference in February.